RP-A501

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Gene Therapy Study of RP-A501 in Male Patients With Danon DiseaseNCT06092034RCKTPhase 2Recruiting2028-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.